Showing results (761-770 of 2,795) with videos related to
Sort By:
Pageof 280
Case Reports in Oncology|April 24, 2018
Genomic Profiling of Two Histologically Distinct Rare Urothelial Cancers in a Clinical Setting to Identify Potential Therapeutic Options for Treatment and Management of DiseaseAndrew N Hesse, William Fabricius, Christian A Thomas, et al.Case Reports in Oncology|April 24, 2018
Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene MonotherapyYota Sato, Taku Fujimura, Yumi Kambayashi, et al.Case Reports in Oncology|October 27, 2021
Refractory Hyperlactatemia and Hypoglycemia in an Adult with Non-Hodgkin's Lymphoma: A Case Report and Review of the Warburg EffectZainab Al Maqrashi, Mary Sedarous, Avinash Pandey, et al.Case Reports in Oncology|October 27, 2021
A Case of a Rapidly Growing Granulocyte Colony-Stimulating Factor-Producing Squamous Cell Carcinoma of the BreastHaruna Noda, Michiko Yamashita, Akari Murakami, et al.Case Reports in Oncology|October 27, 2021
Leptomeningeal Carcinomatosis: A Call for Optimizing Diagnostic Sensitivity by the Hematology LaboratoryBenjamin Lardinois, Laurence Miller, Adrien Randazzo, et al.Case Reports in Oncology|November 1, 2021
Homozygous Germline APC p.I1307K Variants: A Case SeriesAlexa Rosenblum, Michelle Springer, Amanda Eppolito, et al.Case Reports in Oncology|November 1, 2021
Alectinib-Induced Pleural and Pericardial Effusions in ALK-Positive NSCLCMaiken Parm Ulhoi, Boe Sandahl Sorensen, Peter MeldgaardCase Reports in Oncology|November 1, 2021
Pseudoprogression of Malignant Peripheral Nerve Sheath Tumor in Patient with Neurofibromatosis Type 1, a Case ReportAndrés J Lessing, Gregory M Cote, Thomas F DeLaney, et al.Case Reports in Oncology|November 1, 2021
Maffucci Syndrome with Intrahepatic Cholangiocarcinoma: A Case ReportRyoichiro Kobayashi, Akira Shimizu, Koji Kubota, et al.Case Reports in Oncology|November 1, 2021
A Case of Lung Adenocarcinoma with Pulmonary Hypertrophic Osteoarthropathy Showing Pathological Complete Response to a Pembrolizumab-Containing ChemoimmunotherapyNaoki Kataoka, Shoji Oura, Tomoyuki Yamaguchi, et al.Pageof 280